Compare ABUS & HNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABUS | HNRG |
|---|---|---|
| Founded | 2005 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Coal Mining |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 929.6M | 790.0M |
| IPO Year | 2008 | 1995 |
| Metric | ABUS | HNRG |
|---|---|---|
| Price | $4.13 | $15.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $5.00 | ★ $25.38 |
| AVG Volume (30 Days) | ★ 1.6M | 954.1K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 55.26 | ★ 116.78 |
| EPS | N/A | ★ 0.96 |
| Revenue | $14,083,000.00 | ★ $469,466,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $239.71 | $12.12 |
| P/E Ratio | ★ N/A | $16.54 |
| Revenue Growth | ★ 128.21 | 16.09 |
| 52 Week Low | $3.04 | $13.60 |
| 52 Week High | $5.10 | $24.70 |
| Indicator | ABUS | HNRG |
|---|---|---|
| Relative Strength Index (RSI) | 40.44 | 46.02 |
| Support Level | $3.41 | $14.94 |
| Resistance Level | $4.71 | $17.12 |
| Average True Range (ATR) | 0.20 | 0.82 |
| MACD | -0.03 | 0.13 |
| Stochastic Oscillator | 13.57 | 54.48 |
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
Hallador Energy Co is a vertically integrated, independent power producer (IPP) and fuel company with operations in Indiana. The Company operates across multiple stages of the energy value chain, from accredited capacity and energy to coal. The Company's electric operations are located within the Midcontinent Independent System Operator's (MISO) footprint. The company's business is organized based on the services and products it provide in two segments: (i) Electric Operations and (ii) Coal Operations.